To what extent can our intestinal microbiota predict the risk of developing diseases? In the case of multifactorial diseases, bacterial taxa alone do not provide much information, according to a study ...

TechBio company MultiOmic Health (MOH) initially set out to build an artificial intelligence (AI)-enabled platform to research metabolic dysfunction-associated conditions. In just three years, not ...

Genome-wide association studies (GWAS) are effective in detecting common alleles that contribute to the inherited component of common multifactorial diseases. Typically, the alleles identified by this ...

PALO ALTO, Calif., May 1, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to ...

Effect of oxaliplatin-capecitabine first-line chemotherapy and tumor response on serum proteomic profiles in advanced colorectal cancer and identification of diagnostic biomarkers No significant ...

Interview has been edited for readability. AJMC®: What percentage of your practice is dedicated to treating dry eye disease (DED), and has this changed over time? Devries: Approximately 90% of my ...

More than 280,000 people in Germany have multiple sclerosis (MS) and approximately 15,000 new cases are diagnosed each year. This makes MS the most common inflammatory disease of the central nervous ...

Arecent study by UPF’s BCN MedTech Research Unit has outlined a new computational model that simulates the interactions between the proteins present in joint cells and helps pinpoint the factors that ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Artificial intelligence (AI) deep learning is rapidly transforming the biotechnology and pharmaceutical industries. New AI models based on ChatGPT-like algorithms are emerging in many industry ...